作为免疫媒介光皮病的有希望的治疗方法,JAK抑制剂
Mohammad Malekan1, Saeid Taghiloo2, Armaghan Kazeminejad3
1Student Research Committee, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
Drug discovery today
|March 29, 2025
概括
简氏激酶 (JAK) 抑制剂在治疗免疫媒介光皮质症 (IMPs) 方面表现有前途. 本综述评估了这些新型向疗法的有效性和安全性,用于挑战性皮肤疾病,如PMLE和太阳性疹.
科学领域:
- 皮肤病学 皮肤病学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 免疫介导的光皮病 (IMPs) 包括诸如多形光喷发 (PMLE),动作性 (AP),太阳性疹 (SU),慢性动作性皮肤炎 (CAD) 和水性疫苗状 (HV) 等疾病.
- 由于严格的防晒要求和标准治疗的有效性有限,IMP的管理是很困难的,特别是在严重的情况下.
- 简氏激酶 (JAK) 抑制剂代表了一种新的治疗途径,向JAK-STAT信号通路.
研究的目的:
- 审查支持用于IMP的JAK抑制剂的证据.
- 评估JAK抑制剂在治疗各种IMP中的疗效和安全性.
- 为在临床实践中使用JAK抑制剂提供基于证据的理由.
主要方法:
- 对IMP的JAK抑制剂现有研究的文献综述.
- 对病例报告和详细介绍治疗结果的系列进行分析.
- 从已发表的研究中评估疗效和安全数据.
主要成果:
- 从病例报告和系列中获得的初步数据表明,使用JAK抑制剂有积极的结果.
- 雅克抑制剂在管理各种IMP症状方面表现出潜在的潜力.
- 需要进一步的研究才能完全确定疗效和安全性.
结论:
- 雅克抑制剂为免疫媒介光皮病提供了一个有希望的向治疗方法.
- 它们在管理中度至严重的IMP中的作用需要进一步调查.
- 有证据表明,对那些对传统疗法反应有限的患者有潜在的益处.
更多相关视频
05:13LED-Based In Vitro Screening for Assessing Photoactivable Molecules in Bacterial Photodynamic Inactivation
Published on: January 24, 2025
205
13:17In Vitro and In Vivo Evaluation of Photocontrolled Biologically Active Compounds - Potential Drug Candidates for Cancer Photopharmacology
Published on: September 29, 2023
2.1K
相关概念视频
01:27Tumor Immunotherapy
450
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
450
02:34Inhibition of Cdk Activity
4.6K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.6K
01:27Cytotoxic T Cells-mediated Immune Response
819
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
819